EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®) OSLO/LONDON, 22 December 2021: Christmas came early at EXACT Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX) as the clinical-stage precision health.
Underscores the Company's ambition to harness the power of ultrasound in precision therapeutics amplification OSLO, Norway and LONDON, Dec. 6, 2021 /PRNewswire/ Exact Therapeutics AS
/PRNewswire/ Exact Therapeutics AS ("EXACT-Tx", or "the Company" Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic.